120 related articles for article (PubMed ID: 7976251)
1. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma.
Vecek N; Nola M; Marusić M; Ilić J; Babić D; Petrovecki M; Nikolić S; Marinović T; Jukić D; Vecek N
Acta Obstet Gynecol Scand; 1994 Oct; 73(9):730-3. PubMed ID: 7976251
[TBL] [Abstract][Full Text] [Related]
2. [Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma].
Gorchev G; Milkov V
Akush Ginekol (Sofiia); 1992; 31(2):32-3. PubMed ID: 1342555
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer.
Friberg LG; Norén H
Cancer; 1993 Jun; 71(11):3570-4. PubMed ID: 8490906
[TBL] [Abstract][Full Text] [Related]
5. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
7. Steroid hormone receptor content and lymph node status in endometrial cancer.
Morris PC; Anderson JR; Anderson B; Buller RE
Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
[TBL] [Abstract][Full Text] [Related]
8. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
von Minckwitz G; Kaufmann M
Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
[No Abstract] [Full Text] [Related]
9. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
10. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
11. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
[TBL] [Abstract][Full Text] [Related]
12. [Degree of DNA ploidy and steroid hormone receptors as prognostic factors in endometrial carcinoma].
Köhler U; Martin R; Krug H; Bilek K
Zentralbl Gynakol; 1991; 113(20):1086-95. PubMed ID: 1746194
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of hormone receptors in endometrial cancer.
Creasman WT
Cancer; 1993 Feb; 71(4 Suppl):1467-70. PubMed ID: 8431882
[TBL] [Abstract][Full Text] [Related]
14. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of cancer of the endometrium and therapeutic implications].
Michel G; Morice P; Castaigne D; Lanoux P; Pautier P; Lhommé C; Gerbaulet A; Duvillard P
Contracept Fertil Sex; 1998 Jun; 26(6):452-6. PubMed ID: 9691524
[TBL] [Abstract][Full Text] [Related]
16. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients.
Kadar N; Malfetano JH; Homesley HD
Gynecol Oncol; 1993 Sep; 50(3):281-6. PubMed ID: 8406187
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic factors in endometrial carcinoma (EC)].
Gorchev G
Akush Ginekol (Sofiia); 1995; 34(2):51-3. PubMed ID: 8651426
[No Abstract] [Full Text] [Related]
19. Plasminogen activator inhibitors in endometrial adenocarcinoma.
Gleeson NC; Gonsalves R; Bonnar J
Cancer; 1993 Sep; 72(5):1670-2. PubMed ID: 8348499
[TBL] [Abstract][Full Text] [Related]
20. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]